Glaucoma, Alzheimer disease and other dementia: A longitudinal analysis

Ophthalmic Epidemiology

Volumn 19, Issue 5, 2012, Pages 285-292

  Ou, Yvonne ^a   Grossman, Daniel S ^b   Lee, Paul P ^a   Sloan, Frank A ^b  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Dementia; Glaucoma; Longitudinal study; Medicare claims data

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY;

AGED; ALZHEIMER DISEASE; DATABASES, FACTUAL; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INSURANCE CLAIM REVIEW; INTRAOCULAR PRESSURE; LONGITUDINAL STUDIES; MALE; MEDICARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; UNITED STATES;

EID: 84866389524     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2011.649228     Document Type: Article

References (44)

1. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med 2009;360(11):1113-1124.
2. Whitcup SM. Clinical trials in neuroprotection. Prog Brain Res 2008;173:323-335.
3. Sloane PD, Zimmerman S, Suchindran C, et al. The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu Rev Public Health 2002;23:213-231. (Pubitemid 34508073)
4. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006;368(9533):387-403. (Pubitemid 44108123)
5. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985;82(12):4245-4249. (Pubitemid 15053619)
6. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83(13):4913-4917.
7. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009;10(5):333-344.
8. Vickers JC, Craig JE, Stankovich J, et al. The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis Oct 14 2002;8:389-393. (Pubitemid 36153629)
9. Zetterberg M, Tasa G, Palmer MS, et al. Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma. Am J Ophthalmol 2007;143(6):1059- 1060. (Pubitemid 46779037)
10. Copin B, Brezin AP, Valtot F, Dascotte JC, Bechetoille A, Garchon HJ. Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet 2002;70(6):1575-1581. (Pubitemid 34533905)
11. Hinton DR, Sadun AA, Blanks JC, Miller CA. Opticnerve degeneration in Alzheimer's disease. N Engl J Med 1986;315(8):485-487.
12. Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer's disease. Ophthalmology 1990;97(1):9-17. (Pubitemid 20020620)
13. Tsai CS, Ritch R, Schwartz B, et al. Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch Ophthalmol 1991;109(2):199-204.
14. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci 2002;43(4):1077-1087. (Pubitemid 34258276)
15. Guo L, Salt TE, Luong V, et al. Targeting amyloidbeta in glaucoma treatment. Proc Natl Acad Sci USA 2007;104(33):13444-13449.
16. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol 2002;47(3):165-168. (Pubitemid 34253039)
17. Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 2002;133(1):135-137. (Pubitemid 34076513)
18. Tamura H, Kawakami H, Kanamoto T, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci 2006;246(1-2):79-83. (Pubitemid 43815345)
19. Kessing LV, Lopez AG, Andersen PK, Kessing SV. No increased risk of developing Alzheimer disease in patients with glaucoma. J Glaucoma 2007;16(1):47-51. (Pubitemid 46114773)
20. Ukraintseva S, Sloan F, Arbeev K, Yashin A. Increasing rates of dementia at time of declining mortality from stroke. Stroke 2006;37(5):1155-1159. (Pubitemid 43731854)
21. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics Med 1998;17(19):2265-2281.
22. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70(1):41-55.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383. (Pubitemid 17055592)
24. Manitoba Centre for Health Policy. Concept: Charlson Index; 2009. Accessed May 27, 2001 from: http://mchp-appserv.cpe. umanitoba.ca/viewConcept. php?conceptID = 1098
25. Parsons LS. Reducing Bias in Propensity Score Matched-Pair Sample Using Greedy Matching Techniques. Seattle, WA.
26. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thoracic Cardiovasc Surg 2007;134:1128-1135, 1135.e1121-1135. e1123.
27. Normand SL, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 2001;54:387-398. (Pubitemid 32303462)
28. Chandra V, Bharucha NE, Schoenberg BS. Conditions associated with Alzheimer's disease at death: case-control study. Neurology 1986;36(2):209-211. (Pubitemid 16124210)
29. Schwartzbaum J, Ahlbom A, Feychting M. Berkson's Bias reviewed. Eur J Epidemiol 2003;18(12):1109-1112. (Pubitemid 38083955)
30. Rubin GS, West SK, Munoz B, et al. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci 1997;38(3):557-568. (Pubitemid 27143125)
31. Munoz B, West S, Rubin GS, Schein OD, Fried LP, Bandeen-Roche K. Who participates in population based studies of visual impairment? The Salisbury Eye Evaluation project experience. Ann Epidemiol 1999;9(1):53-59. (Pubitemid 29016705)
32. Baker ML, Wang JJ, Rogers S, et al. Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. Arch Ophthalmol 2009;127(5):667-673.
33. Klaver CCW, Ott A, Hofman A, Assink JJM, Breteler MMB, de Jong P. Is age-related maculopathy associated with Alzheimer's disease? The Rotterdam Study. Am J Epidemiol 1999;150(9):963-968. (Pubitemid 29508649)
34. Harding JJ. Cataract, Alzheimer's disease, and other conformational diseases. Curr Opin Ophthalmol 1998;9(1): 10-13. (Pubitemid 28132643)
35. Goldstein LE, Muffat JA, Cherny RA, et al. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet 2003;361(9365):1258-1265. (Pubitemid 36428580)
36. Bjorkdahl C, Sjogren MJ, Zhou X, et al. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. J Neurosci Res 2008;86(6):1343-1352. (Pubitemid 351571908)
37. Demirovic J, Prineas R, Loewenstein D, et al. Prevalence of dementia in three ethnic groups: The South Florida Program on Aging and Health. Ann Epidemiol 2003;13(6): 472-478. (Pubitemid 36870817)
38. Fillenbaum GG, Heyman A, Huber MS, et al. The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol 1998;51(7):587-595. (Pubitemid 28376968)
39. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population ? Prevalence estimates using the 2000 census. Arch Neurol 2003;60(8):1119-1122. (Pubitemid 36975801)
40. Husaini BA, Sherkat DE, Moonis M, Levine R, Holzer C, Cain VA. Racial differences in the diagnosis of dementia and in its effects on the use and costs of health care services. Psychiatric Services 2003;54(1):92-96. (Pubitemid 36043853)
41. Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 2001;56(1):49-56. (Pubitemid 32059651)
42. Clark PC, Kutner NG, Goldstein FC, et al. Impediments to timely diagnosis of Alzheimer's disease in African Americans. J Am Geriatr Soc 2005;53(11):2012-2017. (Pubitemid 41826084)
43. Shadlen MF, Siscovick D, Fitzpatrick AL, Dulberg C, Kuller LH, Jackson S. Education, cognitive test scores, and black-white differences in dementia risk. J Am Geriatr Soc 2006;54(6):898-905. (Pubitemid 43847025)
44. Taylor DH, Jr., Fillenbaum GG, Ezell ME. The accuracy of Medicare claims data in identifying Alzheimer's disease. J Clin Epidemiol 2002;55(9):929-937. (Pubitemid 35246565)